
TBRIF
Healthcare · Medical Devices · $979,946 market cap
Next report
After the close
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Dec 1, 2026 · upcoming | After the close | — | — | — |
| Oct 31, 2021 | Time not confirmed | — | -0.01 | — |
| Jul 31, 2021 | Time not confirmed | — | -0.00 | — |
| Apr 30, 2021 | Time not confirmed | 0.00 | -0.01 | — |
| Jan 31, 2021 | Time not confirmed | 0.00 | -0.01 | — |
| Oct 31, 2020 | Time not confirmed | 0.00 | -0.01 | — |
| Jul 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Jul 31, 2019 | Time not confirmed | 0.00 | 0.00 | — |
| Apr 30, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2018 | Time not confirmed | 0.00 | -0.00 | — |
Therma Bright Inc. acquires, develops, manufactures, and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health, and consumer medical devices for consumer and institutional marketplace. Its products include AcuVid, an antigen and antibody rapid screening test for COVID-19; InterceptCS, a cold sore prevention system, which provides controlled topical heat without the risk…
| Jul 31, 2018 |
| Time not confirmed |
| 0.00 |
| -0.00 |
| — |
| Apr 30, 2018 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2018 | Time not confirmed | 0.00 | -0.00 | — |